TherapeuticsMD, Inc. cotiza a 1.96 USD y tiene una capitalización bursátil de $23M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to …
| Periodo | 2023-08 | 2023-05 | 2023-04 | 2022-11 |
|---|---|---|---|---|
| Real | $-0.24 | $-0.24 | $8.23 | $-3.13 |
| Estimado | $-0.07 | $0.06 | $-1.11 | $-2.04 |
| Sorpresa | -242.9% | -500.0% | +841.4% | -53.4% |
| Métrica | TXMD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -145.3% | -38.6% | -106.7% |
| Net Margin | -18.8% | -33.6% | +14.7% |
| FCF Margin | — | -13.9% | — |
| ROE | -2.1% | -40.4% | +38.3% |
| ROA | -1.5% | -32.0% | +30.5% |
| Current Ratio | 3.02 | 2.84 | +0.18 |
| Debt / Equity | — | 0.28 | — |